Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-041339

Options or other derivatives

  • See Remarks acquired 21,666 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McNeill Jonathan See Remarks 2022-07-05 Grant or award · Stock Option (right to buy) +21,666 21,666 D
Loading xslF345X03/doc4.xml…